Market Research Logo

Autoimmune Disease Therapeutics - Global Market Outlook (2015-2022)

Autoimmune Disease Therapeutics - Global Market Outlook (2015-2022)

According to Stratistics MRC, the Global Autoimmune Disease Therapeutics Market is accounted for $51.2 billion in 2015 and is expected to reach $82.13 billion by 2022 growing at a CAGR of 6.9% during the forecast period. Rising healthcare expenditure in the region is one of the key factors fueling the market growth. On the other hand, insufficient funding in emerging countries and high cost involved in the treatment of the disease are hindering the market. Biologics drug acts as initial line of treatment due to therapeutic capabilities in controlling and treatment of different autoimmune complications.

North America is the largest market for autoimmune disease therapeutics due to increasing incidence of different forms of autoimmune disorders, and government initiatives in the region. Europe is expected to be the second largest market due to rising healthcare infrastructure and penetration of new technologies.

Some of the key players in the market include Johnson & Johnson Inc, Bayer Schering Pharma AG, Elan Corporation Plc, Abbott Laboratories, Genentech Inc, GlaxoSmithKline Plc, Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd., Merck & Co. Inc, Amgen Inc, Eli Lilly and Company, F. Hoffmann-La Roche AG, Biogen Idec Inc, Teva Pharmaceuticals, Industries Limited, UCB S.A., Sanofi-Aventis SA, Novartis AG and Shire Plc.

Distribution Channel:
Drug Stores
Hospitals
Independent Pharmacies
Clinics

Drug Class Covered:
Anti-Inflammatory Drugs
Biologics
Immunosuppressant’s
Nonsteroidal anti-inflammatory drugs
Corticosteroids

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt


What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Autoimmune Disease Therapeutics Market, By Distribution Channel
5.1 Introduction
5.2 Drug Stores
5.3 Hospitals
5.4 Independent Pharmacies
5.5 Clinics
6 Global Autoimmune Disease Therapeutics Market, By Drug Class
6.1 Introduction
6.2 Anti-Inflammatory Drugs
6.3 Biologics
6.4 Immunosuppressant’s
6.5 Nonsteroidal anti-inflammatory drugs
6.6 Corticosteroids
7 Global Autoimmune Disease Therapeutics Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Johnson & Johnson Inc
9.2 Bayer Schering Pharma AG
9.3 Elan Corporation Plc
9.4 Abbott Laboratories
9.5 Genentech Inc
9.6 GlaxoSmithKline Plc
9.7 Bristol-Myers Squibb
9.8 Chugai Pharmaceutical Co. Ltd.
9.9 Merck & Co. Inc
9.10 Amgen Inc
9.11 Eli Lilly and Company
9.12 F. Hoffmann-La Roche AG
9.13 Biogen Idec Inc
9.14 Teva Pharmaceuticals Industries Limited
9.15 UCB S.A.
9.16 Sanofi-Aventis SA
9.17 Novartis AG
9.18 Shire Plc
List of Tables
Table 1 Global Autoimmune Disease Therapeutics Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 3 Global Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 4 Global Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 5 Global Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 6 Global Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 7 Global Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 8 Global Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 9 Global Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 10 Global Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 11 Global Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 12 Global Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
Table 13 North America Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 14 North America Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 15 North America Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 16 North America Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 17 North America Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 18 North America Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 19 North America Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 20 North America Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 21 North America Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 22 North America Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 23 North America Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
Table 24 Europe Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 25 Europe Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 26 Europe Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 27 Europe Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 28 Europe Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 29 Europe Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 30 Europe Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 31 Europe Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 32 Europe Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 33 Europe Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 34 Europe Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
Table 35 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 36 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 37 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 38 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 39 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 40 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 41 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 42 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 43 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 44 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 45 Asia Pacific Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)
Table 46 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Distribution Channel (2013-2022) ($MN)
Table 47 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Drug Stores (2013-2022) ($MN)
Table 48 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 49 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Independent Pharmacies (2013-2022) ($MN)
Table 50 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Clinics (2013-2022) ($MN)
Table 51 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Drug Class (2013-2022) ($MN)
Table 52 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Anti-Inflammatory Drugs (2013-2022) ($MN)
Table 53 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Biologics (2013-2022) ($MN)
Table 54 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Immunosuppressant’s (2013-2022) ($MN)
Table 55 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Nonsteroidal anti-inflammatory drugs (2013-2022) ($MN)
Table 56 Rest of the World Autoimmune Disease Therapeutics Market Outlook, By Corticosteroids (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report